Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome

Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated with increased mortality due to cardiovascular disease. Second-generation antipsychotics (SGAs) play an important role in facilitating MetS. Objective: The study aimed to assess weight changes and alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornetova, Elena G., Kornetov, Alexander N., Mednova, Irina A., Dubrovskaya, Viktoria V., Boiko, Anastasia S., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838009/
https://www.ncbi.nlm.nih.gov/pubmed/31736812
http://dx.doi.org/10.3389/fpsyt.2019.00803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838009/
https://www.ncbi.nlm.nih.gov/pubmed/31736812
http://dx.doi.org/10.3389/fpsyt.2019.00803

Ejemplares similares